← Back to patent-cliff list
(S,S)-[11C]MeNER
Tier C — Watch / trade(S,S)-[11C]MeNER
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NET
Indications (approved)：Multiple sclerosis
Regional status
US
Phase II
2017-10-10
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of (S,S)-[11C]MeNER?
Approved indications include: Multiple sclerosis.
When does the (S,S)-[11C]MeNER patent expire?
No public expiry year is available for (S,S)-[11C]MeNER yet; this page updates once verified.
How do I get a quote for (S,S)-[11C]MeNER intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-09